Follow Us
© 2026 Arizent. All rights reserved.
Medical experts proposed a radical overhaul of how obesity is diagnosed, moving away from relying on body mass alone and adding broader measurements like heart health.
The recommendation signals a long-awaited shift from a single imperfect metric toward a more personalized diagnosis that takes into account a person’s ability to accomplish everyday tasks and the state of their organs. It may also impact the prescription of blockbuster weight-loss drugs.
For reprint and licensing requests for this article, click here.
Helping employees manage symptoms will enhance productivity, engagement and retention – protecting institutional knowledge and strengthening business outcomes.
A look at what the Medicare GLP-1 Bridge Program covers, what it doesn't, and what plan sponsors need to know.
Medicare now covers the medication for weight loss for eligible members, upping the need for corresponding lifestyle and behavioral benefits.
Join a healthcare professional as they discuss how employers can support the management of obesity within their organizations.
Medication paired with behavioral change support gives employers the opportunity to provide a more well-rounded approach to weight management.
